Navigation Links
Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause
Date:6/2/2011

l in the fall. We have completed enrollment to our ongoing tolerability trial, exploring the tolerability and safety of higher doses, and to date, there have been no reports of serious adverse events, no changes to blood pressure, heart rate or lab values and no cases of abnormal uterine bleeding. The brisk pace of enrollment reflects the strong interest in a novel drug that will be in great demand by the 40 million women transitioning through menopause."

"These are exciting times for Bionovo as we are on target to meet our stated timelines for the year. We completed the construction of our manufacturing facility and have commenced GMP manufacturing of Menerba for the Phase 3 clinical trials. Our ongoing animal toxicity studies continue to show Menerba is extremely safe. We have recruited 40 of the 50 clinical sites for the Phase 3 trial and the research community eagerly anticipates seeing the first novel product in 60 years for this indication start late stage clinical testing in the next few months," stated Dr. Isaac Cohen, Chairman and Chief Executive Officer of Bionovo, Inc.

About Menerba

Menerba is an oral drug candidate designed for the safe, effective treatment of vasomotor symptoms (hot flashes) associated with menopause, which is manufactured from botanical sources. Menerba is an estrogen receptor beta (ER-b) selective drug, developed as an alternative to the products currently on the market which have been shown to increase the risk for breast and uterine cancers. It has been shown that the increased risk of breast and uterine cancers is associated with activation of estrogen receptor alpha (ER-a) and that activation of estrogen receptor beta (ER-b) blocks the growth promoting effects on breast cancer cells. The active ingredients in Menerba are derived from botanicals with centuries of recorded safe, effective use in traditional Chinese medicine (TCM). Bionovo recognizes the opportunity to commercialize a product that
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
8. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
9. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... BRUSSEL , 31 juli 2014 De ... van een rekruteringscampagne voor gezonde vrijwilligers van Japanse komaf ... Brussel gevestigde PCRU is één van twee ... met als ideaal levens te verbeteren door de ontdekking ... is de PCRU op zoek naar mannen en vrouwen ...
(Date:7/30/2014)... , July 30, 2014  There is ... chain organization,s success. The 10th Annual Institute for ... Awards for Excellence in Supply Management is open ... further the understanding and importance of supply management ... leadership and best supply management practices.  Entries are ...
(Date:7/30/2014)... -- Advanced Photonix ® (NYSE MKT: API) will announce ... on Monday, August 11, 2014. A press release announcing the ... market and the Company will host a live audio web ... the same day. Participating in the call will ... Risser (COO and Director), and Jeff Anderson ...
Breaking Medicine Technology:Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Institute for Supply Management, Michigan State University to recognize companies with excellent supply management practices 2Advanced Photonix to Webcast Fiscal 2015 First Quarter Earnings 2
... Approximately one-half of all infants are infected with the respiratory ... all children have been infected at least once by the time ... have discovered what makes RSV such a severe and persistent illness. ... his team have discovered that RSV prompts the release of a ...
... Australia, Sept. 3 Cytopia Limited,s (ASX: CYT) Investigational New ... Drug Administration (FDA) review. CYT387 is a small-molecule oral JAK1/JAK2 ... IND application is now active and Cytopia is able to ... , , CYT387 will be the second ...
Cached Medicine Technology:Researchers Find Common Respiratory Virus Hijacks Lung Cells to Stay Alive 2Researchers Find Common Respiratory Virus Hijacks Lung Cells to Stay Alive 3Cytopia's CYT387 Receives FDA Clearance to Start US Clinical Trials 2
(Date:7/30/2014)... (PRWEB) July 30, 2014 Nationally recognized ... CNE, ANEF, who since September 2013 has served as ... became the new dean of the College of Nursing ... move marries her leadership of the NLN, as the ... the top-ranked academic nursing and research institutions in the ...
(Date:7/30/2014)... Within weeks freshman will begin to pour onto college ... will be a time of growth and the start to something ... may not be as easy as it looks. Some sources ... major at least once and many will switch two or three ... are exacerbated when switching in the later years of college. According ...
(Date:7/30/2014)... Throughout the month of August, Restore ... cancer screenings. Using a new technological tool called The ... disease in its early stages. , Oral cancer can ... throat and other areas in and around the mouth. ... Ends Results (SEER) program, 30 percent of oral cancers ...
(Date:7/30/2014)... Cucamonga, CA (PRWEB) July 30, 2014 Serial ... learning how to make millions. However, like most people, in ... Determined to find a better way, Paul carefully studied ... wealth and those who do not. Based on the knowledge ... to not only improve his life and health, but also ...
(Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July 30, 2014 ... to develop dementia, but researchers have been unable to explain ... Specifically, they haven,t been able to figure out the direction ... on dementia, or does dementia cause people to become depressed? ... journal Neurology sheds more light on the mystery. ...
Breaking Medicine News(10 mins):Health News:National League for Nursing Congratulates League President Marsha Adams on Appointment as Dean of College of Nursing at University of Alabama-Huntsville 2Health News:National League for Nursing Congratulates League President Marsha Adams on Appointment as Dean of College of Nursing at University of Alabama-Huntsville 3Health News:Advice to College Freshman from Author Garrett Miller 2Health News:Advice to College Freshman from Author Garrett Miller 3Health News:Restore Dental Offers Complimentary Oral Cancer Screenings in August 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 3Health News:Scientists Shed Light on Link Between Depression, Dementia 2Health News:Scientists Shed Light on Link Between Depression, Dementia 3
... for UGIB should be performed within 24 hour from the admission. ... it should be performed either very early i.e. within 2 ... 6, 12 or 24 hour. Therefore, optimal timing for urgent endoscopy ... article to be published on August 28, 2008 in the ...
... 9 Heritage Victor Valley,Medical Group announced today ... Club. The Victorville Senior Citizen Club sponsors,educational, social ... The computers will be used for work stations ... programs at the Club., "The Victorville Senior ...
... Brinks Hofer Gilson & Lione, one of,the largest intellectual ... that Jacob Cheung-Ka Ong has joined the firm,s Salt ... Cheung-Ka Ong received a B.S. in neuroscience from Brigham ... University of,California-San Diego, La Jolla. He received his J.D. ...
... Bias Correction of Familial Risk Estimates Increases Estimated Melanoma ... , The relative risk of familial melanoma increases substantially ... a large cohort study. The relative risk of familial ... substantially with the correction. , Researchers have used the ...
... (Sept. 9, 2008) Both higher fish consumption and ... development in infants, according to a study of mothers ... breastfeeding were independently beneficial. , "These results, together with ... and the United Kingdom, provide additional evidence that moderate ...
... Firm Will Grow Through Leadership Development and Technological Efficiency ... ... Ga. (Vocus) September 9, 2008 -- http://www.jacksonhealthcare.com/companies.aspx ... of Alpharetta, Ga.-based http://www.locumtenens.com/new_leader08 [LocumTenens.com]. Working ...
Cached Medicine News:Health News:Also in the Sept. 9 JNCI 2Health News:Also in the Sept. 9 JNCI 3Health News:Eating fish while pregnant, longer breastfeeding, lead to better infant development 2Health News:Eating fish while pregnant, longer breastfeeding, lead to better infant development 3Health News:R. Shane Jackson Named President of LocumTenens.com 2Health News:R. Shane Jackson Named President of LocumTenens.com 3
... Finnpipette BioControl multichannel has ... as the single channel ... fits allseven multichannel and ... cone modules. Both pipettes ...
... and best value in high performance electronic ... ultra lightweight design reduce hand fatigue and ... lever tip ejector , Color coding for ... or for greater performance use Hamilton AdvanTip ...
... pro Electronic Pipette is ideal for all ... easy-to-follow display, ergonomically-placed operating buttons, and various ... pipetting and diluting make this a lab ... of a manual pipette without any adverse ...
... The Research pro Electronic Pipette is ... the laboratory. Its easy-to-follow display, ergonomically-placed operating ... pipetting, dispensing, reverse pipetting and diluting make ... the simple functions of a manual pipette ...
Medicine Products: